Literature DB >> 15545012

Purinergic-receptor oligomerization: implications for neural functions in the central nervous system.

Hiruyasu Nakata1, Kazuaki Yoshioka, Toshio Kamiya.   

Abstract

It is becoming clear that the functions of G protein-coupled receptors (GPCRs), the largest family of plasma membrane-localized receptors, are regulated by direct oligomeric formation between GPCRs, as either homo- or hetero-oligomers. This review article explores the mechanistic implications of GPCR dimerization, especially among purinergic receptors, adenosine receptors and P2 receptors, which play critical roles in the regulation of neurotransmission in the central nervous system. Briefly, adenosine receptors are able to form a heteromeric complex with P2 receptors that generates an adenosine receptor with P2 receptor-like agonistic pharmacology. This mechanism may be used to fine-tune purinergic inhibition locally at sites where there is a particular oligomerization structure between purinergic receptors, and to explain the undefined adenosine-like purinergic functions of adenine nucleotides. Purinergic receptors also form oligomers with GPCRs of other families present in the brain, such as dopamine receptors and metabotropic glutamate receptors, to alter the functional properties. The effect of GPCR oligomerization on receptor functions is thus considered as an important system in the central nervous system.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15545012     DOI: 10.1007/bf03033439

Source DB:  PubMed          Journal:  Neurotox Res        ISSN: 1029-8428            Impact factor:   3.911


  38 in total

Review 1.  Dimerization: an emerging concept for G protein-coupled receptor ontogeny and function.

Authors:  Stephane Angers; Ali Salahpour; Michel Bouvier
Journal:  Annu Rev Pharmacol Toxicol       Date:  2002       Impact factor: 13.820

Review 2.  Homo- and hetero-oligomerization of G protein-coupled receptors.

Authors:  Samuel P Lee; Brian F O'Dowd; Susan R George
Journal:  Life Sci       Date:  2003-12-05       Impact factor: 5.037

Review 3.  G-protein-coupled receptor oligomerization and its potential for drug discovery.

Authors:  Susan R George; Brian F O'Dowd; Samuel P Lee
Journal:  Nat Rev Drug Discov       Date:  2002-10       Impact factor: 84.694

Review 4.  Receptors for purines and pyrimidines.

Authors:  V Ralevic; G Burnstock
Journal:  Pharmacol Rev       Date:  1998-09       Impact factor: 25.468

5.  A bioluminescence resonance energy transfer (BRET) system: application to interacting circadian clock proteins.

Authors:  Y Xu; D W Piston; C H Johnson
Journal:  Proc Natl Acad Sci U S A       Date:  1999-01-05       Impact factor: 11.205

6.  Competition of adenine nucleotides for a 1,3-[3H]-dipropyl-8-cyclopentylxanthine binding site in rat vas deferens.

Authors:  A D Smith; D J Cheek; I L Buxton; D P Westfall
Journal:  Clin Exp Pharmacol Physiol       Date:  1997-07       Impact factor: 2.557

7.  Increased AT(1) receptor heterodimers in preeclampsia mediate enhanced angiotensin II responsiveness.

Authors:  S AbdAlla; H Lother; A el Massiery; U Quitterer
Journal:  Nat Med       Date:  2001-09       Impact factor: 53.440

8.  Purification of A1 adenosine receptor from rat brain membranes.

Authors:  H Nakata
Journal:  J Biol Chem       Date:  1989-10-05       Impact factor: 5.157

9.  Agonist-promoted heteromeric oligomerization between adenosine A(1) and P2Y(1) receptors in living cells.

Authors:  Kazuaki Yoshioka; Osamu Saitoh; Hiroyasu Nakata
Journal:  FEBS Lett       Date:  2002-07-17       Impact factor: 4.124

10.  Stable adenine nucleotides inhibit [3H]-noradrenaline release in rabbit brain cortex slices by direct action at presynaptic adenosine A1-receptors.

Authors:  I von Kügelgen; L Späth; K Starke
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-08       Impact factor: 3.000

View more
  5 in total

Review 1.  Allosteric function and dysfunction of the prion protein.

Authors:  Rafael Linden; Yraima Cordeiro; Luis Mauricio T R Lima
Journal:  Cell Mol Life Sci       Date:  2011-10-09       Impact factor: 9.261

2.  Adenosine A(1) receptor: Functional receptor-receptor interactions in the brain.

Authors:  Kathrin Sichardt; Karen Nieber
Journal:  Purinergic Signal       Date:  2007-09-05       Impact factor: 3.765

3.  Activation state of the M3 muscarinic acetylcholine receptor modulates mammalian odorant receptor signaling.

Authors:  Yun Rose Li; Hiroaki Matsunami
Journal:  Sci Signal       Date:  2011-01-11       Impact factor: 8.192

Review 4.  Neurotoxins and neurotoxicity mechanisms. An overview.

Authors:  Juan Segura-Aguilar; Richard M Kostrzewa
Journal:  Neurotox Res       Date:  2006-12       Impact factor: 3.911

5.  Co-localization and functional cross-talk between A1 and P2Y1 purine receptors in rat hippocampus.

Authors:  I Tonazzini; M L Trincavelli; J Storm-Mathisen; C Martini; L H Bergersen
Journal:  Eur J Neurosci       Date:  2007-08-02       Impact factor: 3.386

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.